Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (291-300 of 547) with videos related to

Pageof 55
Sort By:
Digestion|October 12, 2012
First-line therapies in inflammatory bowel diseaseMarc Girardin, Michael Manz, Christine Manser, et al.
Inflammatory Bowel Diseases|June 16, 2006
Profiling adipocytokine secretion from creeping fat in Crohn's diseaseGisela Paul, Andreas Schäffler, Markus Neumeier, et al.
Digestion|January 23, 2010
Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's diseaseCristina Nichita, Marc Stelle, Stephan Vavricka, et al.
Gastroenterology|October 13, 2009
Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2Michael Scharl, Gisela Paul, Achim Weber, et al.
World Journal of Gastroenterology|July 5, 2005
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitroChristian Hafner, Stefanie Meyer, Thomas Langmann, et al.
Plos One|January 29, 2016
Targeting the mTOR Complex by Everolimus in NRAS Mutant NeuroblastomaMichael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, et al.
The American Journal of Clinical Nutrition|July 18, 2022
Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cellsNazek Noureddine, Ivan Hartling, Paulina Wawrzyniak, et al.
Inflammatory Intestinal Diseases|October 1, 2020
Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease CourseJulian Burla, Sena Bluemel, Luc Biedermann, et al.
Therapeutic Advances in Gastroenterology|December 7, 2020
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohortFelicitas Ditrich, Sena Blümel, Luc Biedermann, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trialJames O Lindsay, Mathieu Allez, Miranda Clark, et al.
Pageof 55

Showing results (291-300 of 547) with videos related to

Sort By:
Pageof 55
Digestion|October 12, 2012
First-line therapies in inflammatory bowel diseaseMarc Girardin, Michael Manz, Christine Manser, et al.
Inflammatory Bowel Diseases|June 16, 2006
Profiling adipocytokine secretion from creeping fat in Crohn's diseaseGisela Paul, Andreas Schäffler, Markus Neumeier, et al.
Digestion|January 23, 2010
Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's diseaseCristina Nichita, Marc Stelle, Stephan Vavricka, et al.
Gastroenterology|October 13, 2009
Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2Michael Scharl, Gisela Paul, Achim Weber, et al.
World Journal of Gastroenterology|July 5, 2005
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitroChristian Hafner, Stefanie Meyer, Thomas Langmann, et al.
Plos One|January 29, 2016
Targeting the mTOR Complex by Everolimus in NRAS Mutant NeuroblastomaMichael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, et al.
The American Journal of Clinical Nutrition|July 18, 2022
Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cellsNazek Noureddine, Ivan Hartling, Paulina Wawrzyniak, et al.
Inflammatory Intestinal Diseases|October 1, 2020
Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease CourseJulian Burla, Sena Bluemel, Luc Biedermann, et al.
Therapeutic Advances in Gastroenterology|December 7, 2020
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohortFelicitas Ditrich, Sena Blümel, Luc Biedermann, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trialJames O Lindsay, Mathieu Allez, Miranda Clark, et al.
Pageof 55